Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: J Diabetes Complications. 2008 Apr 16;22(4):267–272. doi: 10.1016/j.jdiacomp.2007.06.010

Table 2.

Laboratory and clinical parameters in the study groups

Group I Group II Group III Group IV P value
UACR 7.8 (6.1) 10.9 (7.8) *683.6 (995.9) *377.7 (717.5) <0.0001
Serum creatinine, mg/dl 0.9 (0.2) 0.8 (0.2) 0.9 (0.4) 0.9 (0.4) 0.207
HbA1c, % 5.6 (0.6) *7.9 (2.1) *9.4 (2.5) 5.4 (0.5) <0.0001
Serum glucose, mg/dl 109 (21.3) *191 (11.1) *237 (12.0) 100 (18.2) <0.0001
Systolic BP, mmHg 126 (14.8) 142 (13.9) 132 (13.2) 129 (22.5) 0.6796
Diastolic BP, mmHg 82 (10.2) 80 (11.3) 81 (11.0) 86 (17.2) 0.0598

Group I: normals; Group II type 2 diabetes mellitus (T2DM) with urinary albumin:creatinine ratio (UACR) <0.03; Group III T2DM with UACR ≥ 0.03; Group IV: non-diabetic with UACR ≥ 0.03; data presented as mean (SD); Data presented as mean (SD);

*

p<0.0001; HbA1c -Hemoglobin A1c